Education
-
Gene therapy in hemophilia a hot topic at the WFH Global Forum 2019
Gene therapy in hemophilia featured heavily at the World Federation of Hemophilia Global Forum held in Montréal November 13 to 14, 2019. Glenn Pierce, MD,...
-
NEW! Non-factor Replacement Hemophilia Therapies eLearning module
For decades, the underlying principle of the management of hemophilia has been quite straightforward: replace the missing factor. As explained in Module 1 of the...
-
NEW! Gene Therapy for Hemophilia eLearning module
Have you heard the latest about gene therapy for hemophilia? Do you understand what genes are, how gene therapy works, and why it sparks such...
-
NEW! Evolution of Treatment Products eLearning module
Evolution of Treatment Products—the much anticipated second module in the Treatment Products eLearning program—has launched! This module explains the evolution of products for the treatment...
-
WFH holds webinar titled Updated Estimates of Prevalence and Prevalence at Birth of Hemophilia
The World Federation of Hemophilia (WFH) has spearheaded a scientific study updating the prevalence of hemophilia to higher numbers than previously estimated and providing, for...
-
Hemophilia, relationships and intimacy: answering your questions
Have you ever had questions about relationships or intimacy? What about questions about your bleeding disorder and how it relates to your relationships, intimacy, and...
-
WFH has spearheaded a scientific study updating the prevalence of hemophilia to higher numbers than previously estimated
The World Federation of Hemophilia (WFH) has spearheaded a scientific study updating the prevalence of hemophilia to higher numbers than previously estimated and providing, for...
-
WBDR experience: Titilope A. Adeyemo at the Lagos University Teaching Hospital
The WFH World Bleeding Disorders Registry (WBDR) is a web-based data entry system that provides a platform for a network of hemophilia treatment centres (HTCs)...
-
Hurry! Earn CME credits with the gene therapy clinical education program
Enhance your knowledge of emerging gene therapy in hemophilia and claim up to 1.75 AMA PRA Category 1 Credits™ in 2019 with Clinical Advances in...
-
New and Updated Inhibitor Primer: A comprehensive backgrounder
Inhibitors are a serious treatment complication that can occur when people with hemophilia are exposed to clotting factor concentrates. Some patients may have an immune...
